-
de Alwis R, Williams KL, Schmid MA, Lai CY, Patel B, Smith SA, Crowe JE, Wang WK, Harris E, de Silva AM, 2014: Dengue viruses are enhanced by distinct populations of serotype crossreactive antibodies in human immune sera[J]. PLoS Pathog, 10, e1004386-. doi: 10.1371/journal.ppat.1004386
-
Enjuanes L, Dediego ML, Alvarez E, Deming D, Sheahan T, Baric R, 2008: Vaccines to prevent severe acute respiratory syndrome coronavirus-induced disease[J]. Virus Res, 133, 45-62. doi: 10.1016/j.virusres.2007.01.021
-
Jaume M, Yip MS, Cheung CY, Leung HL, Li PH, Kien F, Dutry I, Callendret B, Escriou N, Altmeyer R, Nal B, Daëron M, Bruzzone R, Peiris JS, 2011: Anti-severe acute respiratory syndrome coronavirus spike antibodies trigger infection of human immune cells via a pH-and cysteine protease-independent FcgammaR pathway[J]. J Virol, 85, 10582-10597. doi: 10.1128/JVI.00671-11
-
Jolly PE, Weiss HL, 2000: Neutralization and enhancement of HIV-1 infection by Sera from HIV-1 infected individuals who progress to disease at different rates[J]. Virology, 273, 52-59. doi: 10.1006/viro.2000.0401
-
Kam YW, Kien F, Roberts A, Cheung YC, Lamirande EW, Vogel L, Chu SL, Tse J, Guarner J, Zaki SR, Subbarao K, Peiris M, Nal B, Altmeyer R, 2007: Antibodies against trimeric S glycoprotein protect hamsters against SARS-CoV challenge despite their capacity to mediate FcgammaRII-dependent entry into B cells in vitro[J]. Vaccine, 25, 729-740. doi: 10.1016/j.vaccine.2006.08.011
-
Korea Centers for Disease Control and Prevention (2015) Middle east respiratory syndrome coronavirus outbreak in the Republic of Korea, 2015. Osong Public Health Res Perspect 6: 269-278
-
Luo F, Hou W, Yang ZQ, Tang ZJ, Wang Y, Xian QY, Sun LH, 2007: Intratracheal inoculation of severe acute respiratory syndrome coronavirus in monkeys Macaca rhesus[J]. Acta Virol, 51, 171-177.
-
Perl TM, McGeer A, Price CS, 2014: Medusa's ugly head again: from SARS to MERS-CoV[J]. Ann Intern Med, 160, 432-433.
-
Qin E, Shi H, Tang L, Wang C, Chang G, Ding Z, Zhao K, Wang J, Chen Z, Yu M, Si B, Liu J, Wu D, Cheng X, Yang B, Peng W, Meng Q, Liu B, Han W, Yin X, Duan H, Zhan D, Tian L, Li S, Wu J, Tan G, Li Y, Li Y, Liu Y, Liu H, Lv F, Zhang Y, Kong X, Fan B, Jiang T, Xu S, Wang X, Li C, Wu X, Deng Y, Zhao M, Zhu Q, 2006: Immunogenicity and protective efficacy in monkeys of purified inactivated Vero-cell SARS vaccine[J]. Vaccine, 24, 1028-1034. doi: 10.1016/j.vaccine.2005.06.038
-
Reed LJ, Muench H, 1938: A simple method of estimating fifty percent endpoints[J]. Am J Hyg, 27, 493-497.
-
Roberts A, Lamirande EW, Vogel L, Jackson JP, Paddock CD, Guarner J, Zaki SR, Sheahan T, Baric R, Subbarao K, 2008: Animal models and vaccines for SARS-CoV infection[J]. Virus Res, 133, 20-32. doi: 10.1016/j.virusres.2007.03.025
-
Rota PA, Oberste MS, Monroe SS, Nix WA, Campagnoli R, Icenogle JP, Peñaranda S, Bankamp B, Maher K, Chen MH, Tong S, Tamin A, Lowe L, Frace M, DeRisi JL, Chen Q, Wang D, Erdman DD, Peret TC, Burns C, Ksiazek TG, Rollin PE, Sanchez A, Liffick S, Holloway B, Limor J, McCaustland K, Olsen-Rasmussen M, Fouchier R, Günther S, Osterhaus AD, Drosten C, Pallansch MA, Anderson LJ, Bellini WJ, 2003: Characterization of a novel coronavirus associated with severe acute respiratory syndrome[J]. Science, 300, 1394-1399. doi: 10.1126/science.1085952
-
Takano T, Kawakami C, Yamada S, Satoh R, Hohdatsu T, 2008: Antibody-dependent enhancement occurs upon re-infection with the identical serotype virus in feline infectious peritonitis virus infection[J]. J Vet Med Sci, 70, 1315-1321. doi: 10.1292/jvms.70.1315
-
Wang SF, Tseng SP, Yen CH, Yang JY, Tsao CH, Shen CW, Chen KH, Liu FT, Liu WT, Chen YM, Huang JC, 2014: Antibodydependent SARS coronavirus infection is mediated by antibodies against spike proteins[J]. Biochem Biophys Res Commun, 451, 208-214. doi: 10.1016/j.bbrc.2014.07.090
-
Woo PC, Lau SK, Tsoi HW, Chen ZW, Wong BH, Zhang L, Chan JK, Wong LP, He W, Ma C, Chan KH, Ho DD, Yuen KY, 2005: SARS coronavirus spike polypeptide DNA vaccine priming with recombinant spike polypeptide from Escherichia coli as booster induces high titer of neutralizing antibody against SARS coronavirus[J]. Vaccine, 23, 4959-4968. doi: 10.1016/j.vaccine.2005.05.023
-
Yip MS, Leung NH, Cheung CY, Li PH, Lee HH, Daëron M, Peiris JS, Bruzzone R, Jaume M, 2014: Antibody-dependent infection of human macrophages by severe acute respiratory syndrome coronavirus[J]. Virol J, 11, 82-. doi: 10.1186/1743-422X-11-82
-
Zhou J, Wang W, Zhong Q, Hou W, Yang Z, Xiao SY, Zhu R, Tang Z, Wang Y, Xian Q, Tang H, Wen L, 2005: Immunogenicity, safety, and protective efficacy of an inactivated SARS-associated coronavirus vaccine in rhesus monkeys[J]. Vaccine, 23, 3202-3209. doi: 10.1016/j.vaccine.2004.11.075